Unlock instant, AI-driven research and patent intelligence for your innovation.

Glucoside containing 1,2,3-triazole structure, preparation method and application

A technology of glucopyranoside and triazole, which is applied in the field of type 2 sodium glucose transporter inhibitor and its preparation, and can solve the problems of hepatotoxicity, weight and the like

Inactive Publication Date: 2009-08-19
TIANJIN INSTITUTE OF PHARMA RESEARCH
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These drugs have good therapeutic effects, but long-term treatment has safety issues such as hepatotoxicity and weight gain

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Glucoside containing 1,2,3-triazole structure, preparation method and application
  • Glucoside containing 1,2,3-triazole structure, preparation method and application
  • Glucoside containing 1,2,3-triazole structure, preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] 4-Benzyl-1,2,3-triazol-1-yl β-D-glucopyranoside (I-1)

[0035]

[0036] A 100mL round bottom flask was added with 3.73g (10mmol) of compound II, 1.16g (10mmol) of compound III-1 and 30mL of absolute ethanol, and the reaction mixture was heated and refluxed for 12 hours under electromagnetic stirring, and cooled. The solvent was evaporated from the reaction mixture on a rotary evaporator, and the residue was purified by column chromatography to obtain the pure compound IV-1. The obtained compound IV-1 was dissolved in 100mL of absolute methanol with 0.10g (1.85mmol) of solid MeONa dissolved in advance, stirred at room temperature for 1 hour, then added 5.0g of dry 732 type strongly acidic cation exchange resin, stirred at room temperature 3 hours. The resin was removed by suction filtration, and the filtrate was evaporated to dryness to obtain a white solid, which was dried to obtain Compound I-1. Colorless crystals, 2.73g, yield 85%. ESI-MS, m / z=322 ([M+H] + ). ...

Embodiment 2

[0039] 4-[(2-Chlorophenyl)methyl]-5-methyl-1,2,3-triazol-1-yl β-D-glucopyranoside (I-2)

[0040]

[0041]A 100mL round bottom flask was added with 3.73g (10mmol) of compound II, 1.65g (10mmol) of compound III-2 and 30mL of absolute ethanol, and the reaction mixture was heated to reflux for 12 hours under electromagnetic stirring and cooled. The solvent was evaporated from the reaction mixture on a rotary evaporator, and the residue was purified by column chromatography to obtain the pure compound IV-2. The obtained compound IV-2 was dissolved in 100mL of absolute methanol with 0.10g (1.85mmol) of solid MeONa dissolved in advance, stirred at room temperature for 1 hour, then added 5.0g of dry 732 type strongly acidic cation exchange resin, stirred at room temperature 3 hours. The resin was removed by suction filtration, and the filtrate was evaporated to dryness to obtain a white solid, which was dried to obtain compound I-2. Colorless crystals, 3.18g, yield 86%. ESI-MS, ...

Embodiment 3

[0044] 4-[(4-Ethylphenyl)methyl]-5-methyl-1,2,3-triazol-1-yl β-D-glucopyranoside (I-3)

[0045]

[0046] A 100mL round bottom flask was added with 3.73g (10mmol) of compound II, 1.58g (10mmol) of compound III-3 and 30mL of absolute ethanol, and the reaction mixture was heated and refluxed for 12 hours under electromagnetic stirring, and cooled. The solvent was evaporated from the reaction mixture on a rotary evaporator, and the residue was purified by column chromatography to obtain the pure compound IV-3. The obtained compound IV-3 was dissolved in 100mL of anhydrous methanol with 0.10g (1.85mmol) of solid MeONa dissolved in advance, stirred at room temperature for 1 hour, then added 5.0g of dry 732 type strongly acidic cation exchange resin, stirred at room temperature 3 hours. The resin was removed by suction filtration, and the filtrate was evaporated to dryness to obtain a white solid, which was dried to obtain compound I-3. Colorless crystals, 2.94g, yield 81%. ESI...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the diabetes-related drug field. More specifically, the invention relates to an sodium glucose transporter 2 (SGLT2) inhibitor containing a 1,2,3-triazolylglucoside structure, a preparation method and application thereof to preparation of antidiabetic drugs, wherein, radicals are defined as in the specification.

Description

technical field [0001] The invention relates to the field of medicine related to diabetes. Specifically, the present invention relates to a type 2 sodium glucose transporter (SGLT2) inhibitor containing 1,2,3-triazolyl glucoside structure and a preparation method thereof, as well as a drug combination containing them, which have a therapeutic effect on diabetes things. Background technique [0002] There are currently about 170 million diabetics in the world, and the vast majority are type II (ie non-insulin-dependent) diabetics. At present, the traditional drugs used in clinical treatment of diabetes mainly include metformin, sulfonylureas and insulin drugs, as well as thiazolidinedione drugs, α-glucosidase inhibitors and dipeptidyl peptidase- IV inhibitors, etc. These drugs have good therapeutic effects, but long-term treatment has safety issues such as hepatotoxicity and weight gain. [0003] Sodium glucose transporter type 2 (SGLT2) is a new target for diabetes treat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07H19/056C07H1/00A61K31/7056A61P3/10
Inventor 赵桂龙徐为人王玉丽李祎亮邹美香王致峰刘巍谭初兵汤立达
Owner TIANJIN INSTITUTE OF PHARMA RESEARCH